Ridgecrest Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$695K Sell
24,738
-509
-2% -$13.6K 0.38% 49
2025
Q4
$629K Sell
25,247
-3,255
-11% -$82.1K 0.34% 48
2025
Q3
$726K Buy
28,502
+480
+2% +$11.8K 0.33% 53
2025
Q2
$679K Sell
28,022
-1,293
-4% -$30.2K 0.36% 53
2025
Q1
$743K Buy
29,315
+1,074
+4% +$28.1K 0.39% 50
2024
Q4
$749K Sell
28,241
-6,817
-19% -$185K 0.41% 44
2024
Q3
$1.01M Sell
35,058
-3,519
-9% -$103K 0.53% 40
2024
Q2
$1.08M Sell
38,577
-6,934
-15% -$191K 0.65% 34
2024
Q1
$1.26M Sell
45,511
-4,015
-8% -$111K 0.75% 31
2023
Q4
$1.43M Sell
49,526
-2,779
-5% -$84K 0.94% 25
2023
Q3
$1.73M Sell
52,305
-300
-0.6% -$10.6K 1.22% 20
2023
Q2
$1.93M Buy
52,605
+175
+0.3% +$6.81K 1.28% 18
2023
Q1
$2.14M Sell
52,430
-100
-0.2% -$4.32K 1.52% 18
2022
Q4
$2.69M Sell
52,530
-150
-0.3% -$7.19K 2.04% 15
2022
Q3
$2.31M Sell
52,680
-17,519
-25% -$851K 1.88% 15
2022
Q2
$3.68M Buy
70,199
+15
+0% +$764 2.68% 11
2022
Q1
$3.63M Hold
70,184
2.31% 12
2021
Q4
$4.14M Buy
70,184
+4,115
+6% +$204K 2.02% 14
2021
Q3
$2.84M Buy
66,069
+2,430
+4% +$108K 1.55% 18
2021
Q2
$2.49M Buy
63,639
+1,815
+3% +$70.6K 1.56% 18
2021
Q1
$2.24M Buy
+61,824
New +$2.2M 2.14% 13

Other funds holding PFE

Ridgecrest Wealth Partners's PFE Position: Q1 2026 in Review

Ridgecrest Wealth Partners reduced its Pfizer (PFE) stake by 2% in Q1 2026, selling an estimated $13.6K and leaving 24,738 shares worth $695K. The position accounts for 0.38% of the portfolio, ranked #49.

Ridgecrest Wealth Partners first reported a position in PFE in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.14M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Ridgecrest Wealth Partners held 24,738 shares of Pfizer worth $695K as of Q1 2026.
  • Ridgecrest Wealth Partners sold 509 Pfizer shares in Q1 2026, an estimated $13.6K.
  • Pfizer made up 0.38% of Ridgecrest Wealth Partners's portfolio in Q1 2026, its #49 holding.
  • Ridgecrest Wealth Partners first reported a position in Pfizer in Q1 2021 and has held it in 21 quarters since.
  • Ridgecrest Wealth Partners's Pfizer position peaked at $4.14M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ridgecrest Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.